Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antibody Structure01:10

Antibody Structure

51.8K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
51.8K
Allergic Reactions02:06

Allergic Reactions

26.4K
Overview
26.4K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Hypersensitivities01:30

Hypersensitivities

7.3K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

280
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
280

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sublingual immunotherapy tablets in monosensitized and polysensitized adults with allergic rhinoconjunctivitis.

Allergy and asthma proceedings·2023
Same author

Allergy immunotherapy for allergic fungal respiratory diseases.

Allergy and asthma proceedings·2023
Same author

The Art of Immunotherapy.

The journal of allergy and clinical immunology. In practice·2023
Same author

The Art of Dosing for Subcutaneous Immunotherapy in North America.

The journal of allergy and clinical immunology. In practice·2023
Same author

Allergy immunotherapy: Literature Review 2022.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2023
Same author

Extrapolating Evidence-Based Medicine of AIT Into Clinical Practice in the United States.

The journal of allergy and clinical immunology. In practice·2022

Related Experiment Video

Updated: May 3, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

22.5K

Allergen immunotherapy: where is it now?

Harold S Nelson1

  • 1National Jewish Medical and Research Center, Denver, CO 80206, USA. nelsonh@njc.org

The Journal of Allergy and Clinical Immunology
|March 6, 2007
PubMed
Summary

Subcutaneous allergen immunotherapy (SCIT) effectively treats allergies but has safety and convenience drawbacks. Research explores new methods like sublingual or recombinant approaches to improve treatment accessibility and efficacy.

Area of Science:

  • Immunology
  • Allergy and Clinical Immunology
  • Pharmacology

Background:

  • Subcutaneous allergen immunotherapy (SCIT) is a proven treatment for allergies like Hymenoptera venom sensitivity, allergic rhinitis, and allergic asthma.
  • SCIT can prevent the development of new allergies and the progression of allergic rhinitis to asthma.
  • Established benefits of SCIT include long-lasting effects even after treatment completion.

Purpose of the Study:

  • To review the established efficacy of SCIT for allergic conditions.
  • To identify the limitations of SCIT, including safety concerns and inconvenience.
  • To explore novel approaches aimed at enhancing the safety and convenience of allergen immunotherapy.

Main Methods:

  • Review of existing scientific literature on allergen immunotherapy.

More Related Videos

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Published on: April 21, 2019

15.9K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

9.9K

Related Experiment Videos

Last Updated: May 3, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

22.5K
Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Published on: April 21, 2019

15.9K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

9.9K
  • Analysis of current research into alternative administration routes (e.g., sublingual).
  • Investigation of advanced techniques such as recombinant DNA technology for modifying allergen extracts.

    • Main Results:

    • SCIT demonstrates significant clinical effectiveness and lasting benefits for various allergic conditions.
    • Safety concerns and the need for frequent clinic visits limit widespread SCIT adoption.
    • Emerging strategies focus on improving allergen extracts' safety and patient convenience.

    Conclusions:

    • Despite its effectiveness, SCIT's limitations necessitate the development of improved immunotherapy methods.
    • Novel approaches, including sublingual administration and recombinant technology, show promise for safer and more convenient allergy treatments.
    • Future research aims to optimize allergen immunotherapy to broaden its accessibility and patient adherence.